Dexcom's profit beats estimates on strong glucose monitor demand [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
continuous glucose monitors, but its shares slid 7% after the bell as annual sales forecast was largely below estimates. The company and rival Abbott currently dominate the market for continuous glucose monitors — the devices that track blood glucose levels every few minutes without the need for finger stick tests. Dexcom's total revenue rose 24% to $921 million for the three months ended March 31, beating analysts' average estimate of $909.24 million, according to LSEG data. The company raised the lower end of its 2024 revenue forecast by $50 million, and now expects it to be between $4.20 billion and $4.35 billion. But the midpoint of the new range was below analysts' estimate of $4.32 billion. The California-based company's latest continuous glucose monitor system, G7, was cleared in the United States in 2022. Its another product, Stelo, was cleared by the U.S. FDA in March for use without a prescription from a healthcare provider. Dexcom posted adjusted profit of 32 cent
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Market Analysis Forecasts Substantial Growth for Global Artificial Pancreas Device Systems - Projections to 2032 - Technological Innovations and Regulatory Support [Yahoo! Finance]Yahoo! Finance
- Can DexCom, Inc.'s (NASDAQ:DXCM) ROE Continue To Surpass The Industry Average? [Yahoo! Finance]Yahoo! Finance
- Brace for Pressure: DataGrail Reports Worldwide Surge in Data Privacy Requests [Yahoo! Finance]Yahoo! Finance
- DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Here is Why Growth Investors Should Buy DexCom (DXCM) Now [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 4/25/24 - Beat
DXCM
Sec Filings
- 5/2/24 - Form 4
- 4/30/24 - Form 144
- 4/25/24 - Form 10-Q
- DXCM's page on the SEC website